• Teva Pharmaceutical Industries Limited (TEVA)/Active Biotech AB (BTPC) MS Pill Accepted for Review in Europe More...

• NuPathe Inc. (PATH) Announces Migraine Patch NDA Resubmission More...

• Janssen Submits Applications Requesting Approval of SIMPONI&#0174 in U.S. and Europe for Treatment of Moderately to Severely Active Ulcerative Colitis More...

• FDA Approves Ferring Pharmaceuticals PREPOPIK™ for Colonoscopy Prep More...

• Alnylam Pharmaceuticals (ALNY) Gains on Treatment Data for Deadly Nerve Disease More...

• AstraZeneca PLC (AZN) Starts New Study of Heart Drug Versus Rival More...

• Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) Announces Publication of Key Preclinical Data for a Novel Oral, First-in-class New Chemical Entity (NCE) Sigma-1 Receptor Antagonist (E-52862), that has Completed Phase I and Initiated its Phase II Clinical Trial Program More...

• Anavex Life Sciences Corp. (AVXL.OB) Presents Compelling Data at World's Largest Alzheimer's Conference More...

• Nuvilex Announces Substantial Development in Pancreatic Cancer Research More...

• Sodium Buildup in Brain Linked to MS, Center for Magnetic Resonance in Biology and Medicine Study More...

• Poor Sleep May Age Your Brain, Brigham and Women's Hospital Study More...

• Amnestic Mild Cognitive Impairment Doubles Risk of Death, Albert Einstein College of Medicine and Montefiore Medical Center Reveal More...

• Weight Loss Today Keeps the Doctor Away, Concordia University Study More...

• Grifols Initiates Safety Study of Inhaled Alpha1-Proteinase Inhibitor (Human) Following Orphan Drug D

• ERT Granted Patents on Clinical Trial Participant Compliance More...

• USPTO Grants Butamax™ Advanced Biofuels LLC. a Further KARI Enzyme Patent More...

• Integrity Life Sciences Announces Two US Patents More...

• Sanofi Pasteur (SASY.PA) Begins Shipping Fluzone® Influenza Virus Vaccine in U.S. for 2012-2013 Season More...

• MedImmune (AZN) Slashes 200 Jobs in R&D Restructuring More...

• Chugai Pharmaceutical Co., Ltd. (Japan) to Invest $150 Million in Singapore More...

• BioData Inc. Closes Series B Funding Round With Digital Science More...

• Isotechnika Pharma Inc. (ISA.TO) Receives Additional Funding From the Government of Canada for NICAM Program More...

• Keiretsu Forum Members Make Substantial Bet on Savara More...

• Federal Trade Commission OKs Novartis AG (NVS)' $1.5 Billion Fougera (AAA) Buy With Divestitures More...

• Stevens Institute of Technology and mPhase Technologies, Inc. (XDSL) to Partner on Research and Business More...

• Clinipace Inc. Selected to Manage Prometheus Laboratories Inc. Oncology Program More...

• Clovis Oncology (CLVS) and Array BioPharma, Inc. (ARRY) Announce Agreement to Discover Novel Mutant KIT Inhibitor More...

• BioTime (BTX) Signs Agreements With Jade Therapeutics for Ophthalmological Drug Delivery Applications of HyStem® Technology More...

• Biogen Idec, Inc. (Massachusetts) (BIIB) Announces Collaboration With Leading Research Institutions to Sequence Genomes of Patients With ALS More...

• ZIOPHARM Oncology, Inc. (ZIOP.OB) Announces New Executive Team More...

• Biodesix, Inc. Appoints Vice President of Clinical Development & Medical Affairs More...

• PPD, Inc. (PPDI) Names Louis Renzetti, Ph.D., Vice President of Strategic Laboratory Operations More...

• ADC Therapeutics Appoints Former Genmab A/S (GEN.CO) VP Dr Patrick van Berkel as Senior VP of R&D More...

• CureMark Announces Executive Promotions More...

• Affymetrix (Santa Clara, California) (AFFX) to Host Conference Call on July 31st, 2012 to Announce Second Quarter 2012 Operating Results More...

• Ariad Pharmaceuticals, Inc. (ARIA) to Webcast Conference Call on Second Quarter 2012 Financial Results More...

• Biomet Inc. (BMET) Announces Fourth Quarter and Fiscal Year 2012 Preliminary Financial Results More...

• Successful Launch on the Global Market and First Tactivo™ Order for Precise Biometrics AB More...

• Fibrocell Science, Inc. Announces Second Quarter 2012 LAVIV Order Information More...

• Fire at Merck & Co., Inc. (MRK) Plant Under Investigation More...

• Merck & Co., Inc. (MRK)'s Schering-Plough Corporation (SGP)'s K-Dur Pay-for-Delay Ruling Reversed More...

• Tekmira Pharmaceuticals Corporation Provides Periodic Update to Shareholders Regarding Litigation More...

• Organovo Announces Relocation and Commencement of Operations at Larger Facility More...